Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.297 USD | -11.96% |
|
-5.49% | +53.10% |
Business Summary
Number of employees: 76
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies
100.0
%
| 31 | 100.0 % | 6 | 100.0 % | -80.69% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 25 | 80.4 % | 6 | 100.0 % | -75.97% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 22-07-24 |
Dolores Schendel
CTO | Chief Tech/Sci/R&D Officer | - | 14-04-30 |
Pamela Keck
IRC | Investor Relations Contact | - | 23-01-31 |
Christian Schmid
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-08-11 | |
Frank Mathias
BRD | Director/Board Member | 62 | 18-05-14 |
Anthony Man
BRD | Director/Board Member | 68 | 20-12-15 |
Gerd Zettlmeissl
CHM | Chairman | 68 | 16-12-31 |
Ronald Scott
BRD | Director/Board Member | 69 | 17-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,475,189 | 28,605,076 ( 97.05 %) | 0 | 97.05 % |
Company contact information
![address Medigene AG(MDGEF)](https://cdn.zonebourse.com/static/address/120792369.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- MDG1 Stock
- MDGEF Stock
- Company Medigene AG